Activation of the interleukin-34 inflammatory pathway in response to influenza a virus infection

American Journal of the Medical Sciences

Volumn 349, Issue 2, 2015, Pages 145-150

  Yu, Guozheng ^a   Bing, Yuntao ^a   Zhu, Siying ^a   Li, Wei ^b   Xia, Lin ^c   Li, Yong ^d   Liu, Zhisu ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI CANCER HOSPITAL   (China)

^c Department of geratology Huangshi Central Hospital   (China)

^d HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Inflammatory; Influenza A virus; Interleukin 22; Interleukin 34

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN 34; MESSENGER RNA; SMALL INTERFERING RNA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; INTERLEUKIN-34, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEEDBACK SYSTEM; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; TH17 CELL; AUTOCRINE EFFECT; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFLAMMATION; INFLUENZA; METABOLISM; MIDDLE AGED; PARACRINE SIGNALING; PATHOLOGY; VIROLOGY;

ADULT; AUTOCRINE COMMUNICATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERLEUKINS; MALE; MIDDLE AGED; PARACRINE COMMUNICATION; RNA, SMALL INTERFERING; TH17 CELLS;

EID: 84923700314     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000373     Document Type: Article

References (26)

1. Medina RA, Garcia-Sastre A. Influenza a viruses: new research developments. Nat Rev Microbiol 2011;9:590-603
2. Neumann G, Brownlee GG, Fodor E, et al. Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004;283:121-43
3. Hurt AC, Chotpitayasunondh T, Cox NJ, et al. Antiviral resistance during the 2009 influenza A H1-1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis 2012;12:240-8
4. Rappuoli R, Dormitzer PR. Influenza: options to improve pandemic preparation. Science 2012;336:1531-3
5. WHO. Available at: http://www.who.int/influenza/human-animal-interface/H5-1-cumulative-table-archives/en/index.html 2013. Accessed January 24, 2014
6. Teijaro JR, Walsh KB, Cahalan S, et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 2011;146:980-91
7. Iwasaki A, Medzhitov R. A new shield for a cytokine storm. Cell 2011;146:861-2
8. Jewell NA, Cline T, Mertz SE, et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 2010;84:11515-22
9. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457:722-5
10. Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev 2013;252:116-32
11. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241-54
12. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-67
13. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008;14: 275-81
14. Zheng Y, Danilenko DM, Valdez P, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648-51
15. Van Belle AB, de Heusch M, Lemaire MM, et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice. J Immunol 2012;188:462-9
16. Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008; 320:807-11
17. Chemel M, Le Goff B, Brion R, et al. Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Ann Rheum Dis 2012;71:150-4
18. Hwang SJ, Choi B, Kang SS, et al. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res Ther 2012;14:R14
19. Baud'Huin M, Renault R, Charrier C, et al. Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKLinduced osteoclastogenesis. J Pathol 2010;221:77-86
20. Wang Y, Szretter KJ, Vermi W, et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 2012;13:753-60
21. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 2002;99:111-20
22. Paget C, Ivanov S, Fontaine J, et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J Biol Chem 2012;287:8816-29
23. Wolk K, Witte E, Witte K, et al. Biology of interleukin-22. Semin Immunopathol 2010;32:17-31
24. Manel N, Unutmaz D, Littman DR. The differentiation of human T (H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008;9: 641-9
25. Puissegur MP, Botanch C, Duteyrat JL, et al. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol 2004;6:423-33
26. Petanidis S, Anestakis D, Argyraki M, et al. Differential expression of IL-17, 22 and 23 in the progression of colorectal cancer in patients with K-ras mutation: ras signal inhibition and crosstalk with GM-CSF and IFN-gamma. PLoS One 2013;8:e73616